Skip to main content
. 2024 Aug 28;15(4):1627–1635. doi: 10.21037/jgo-24-497

Figure 2.

Figure 2

Comparison of progression-free survival between the combined group and the control group in patients with intermediate-to-advanced hepatocellular carcinoma.